Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Drug Discovery Today|February 10, 2022
Exclusive modifications of NuMA in malignant epithelial cells: A potential therapeutic mechanismMalka Cohen-ArmonCancers|June 25, 2020
The Modified Phenanthridine PJ34 Unveils an Exclusive Cell-Death Mechanism in Human Cancer CellsMalka Cohen-ArmonTrends in Pharmacological Sciences|October 24, 2007
PARP-1 activation in the ERK signaling pathwayMalka Cohen-ArmonInternational Journal of Molecular Sciences|April 28, 2023
Are Voltage Sensors Really Embedded in Muscarinic Receptors?Malka Cohen-ArmonCell Death & Disease|July 18, 2025
The post-translational modification of NuMA in cancer cells is a new target for cancer eradicationMalka Cohen-ArmonCells|May 14, 2022
A Long-Lasting PARP1-Activation Mediates Signal-Induced Gene ExpressionMalka Cohen-ArmonOncotarget|July 19, 2018
PARP1-Erk synergism in proliferating cellsLeonid Visochek, Malka Cohen-ArmonMolecular Psychiatry|January 6, 2026
Synaptic potentiation requires PARP1 activation: prevailing concepts are revisitedMalka Cohen-Armon, Menahem SegalSignal Transduction and Targeted Therapy|April 18, 2019
Signal-induced PARP1-Erk synergism mediates IEG expressionMalka Cohen-Armon, Adva Yeheskel, John M PascalJournal of Molecular Neuroscience : MN|March 29, 2003
Stimulation-induced modifications in Go proteins examined in giant fused synaptosomesNoya Dekel, Leonid Visochek, Yosef Anis, et al.Pageof 3